John A. MacPhee
Chief Executive Officer at The Jed Foundation
Profile
John A.
MacPhee currently works at The Jed Foundation, as Chief Executive Officer & Executive Director from 2011 and BlackThorn Therapeutics, Inc., as Director.
Mr. MacPhee also formerly worked at Adamas Pharmaceuticals LLC, as Independent Director from 2013 to 2021, Bottom Line, as Director, Endo Generics Holdings, Inc., as Executive Vice President, Par Pharmaceutical, Inc., as Executive Vice President from 2005 to 2011, and Forest Pharmaceuticals, Inc., as Vice President-Marketing from 2001 to 2004.
Mr. MacPhee received his graduate degree from The Trustees of Columbia University in The City of New York, Masters Business Admin degree in 1996 from New York University, and undergraduate degree from Columbia College (New York).
John A. MacPhee active positions
| Companies | Position | Start |
|---|---|---|
BlackThorn Therapeutics, Inc.
 BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blackthorn Therapeutics, Inc. manufactures and markets medicines for neuro developmental disorders. The company is headquartered in San Francisco, CA. | Director/Board Member | - |
The Jed Foundation
 The Jed Foundation Miscellaneous Commercial ServicesCommercial Services The Jed Foundation exists to protect emotional health and prevent suicide for nation's teens and young adults. It develops expert resources and create partnerships. The firm educates and equip students, families and communities. The company was founded in 2000 and is headquartered in New York, NY. | Chief Executive Officer | 21/09/2011 |
Former positions of John A. MacPhee
| Companies | Position | End |
|---|---|---|
| ADAMAS PHARMACEUTICALS, INC. | Director/Board Member | 23/11/2021 |
| PAR PHARMACEUTICAL COMPANIES, INC. | Corporate Officer/Principal | 30/01/2011 |
Par Pharmaceutical, Inc.
 Par Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Par Pharmaceutical, Inc. manufactures and markets generic drugs and pharmaceuticals products. It produces drugs for hypertension, inflammation, depression and pain. The firm distributes its products in the semi-solid form of a cream. The company was founded in 1978 and is headquartered in Chestnut Ridge, NY. | Corporate Officer/Principal | 31/12/2010 |
Forest Pharmaceuticals, Inc.
 Forest Pharmaceuticals, Inc. Forest ProductsNon-Energy Minerals Forest Pharmaceuticals, Inc. manufactures, distributes, and sells forest-branded prescription products in the United States and Puerto Rico. The company is headquartered in St. Louis, MO. | Sales & Marketing | 30/11/2004 |
Bottom Line
 Bottom Line Miscellaneous Commercial ServicesCommercial Services Bottom Line is a non-profit organization. It helps thousands of low-income and first-generation students get to college. The organization was founded in 1997 and is headquartered in Boston, MA. | Director/Board Member | - |
Training of John A. MacPhee
| The Trustees of Columbia University in The City of New York | Graduate Degree |
| New York University | Masters Business Admin |
| Columbia College (New York) | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Endo Generics Holdings, Inc.
 Endo Generics Holdings, Inc. Pharmaceuticals: GenericHealth Technology Endo Generics Holdings, Inc. develops, manufactures, and markets generic pharmaceutical products. It also offers dosage, branded, and generic sterile injectable products. The company was founded in 1978 and is headquartered in New York, NY. | Health Technology |
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA. | Health Technology |
Par Pharmaceutical, Inc.
Par Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Par Pharmaceutical, Inc. manufactures and markets generic drugs and pharmaceuticals products. It produces drugs for hypertension, inflammation, depression and pain. The firm distributes its products in the semi-solid form of a cream. The company was founded in 1978 and is headquartered in Chestnut Ridge, NY. | Health Technology |
Forest Pharmaceuticals, Inc.
Forest Pharmaceuticals, Inc. Forest ProductsNon-Energy Minerals Forest Pharmaceuticals, Inc. manufactures, distributes, and sells forest-branded prescription products in the United States and Puerto Rico. The company is headquartered in St. Louis, MO. | Non-Energy Minerals |
The Jed Foundation
The Jed Foundation Miscellaneous Commercial ServicesCommercial Services The Jed Foundation exists to protect emotional health and prevent suicide for nation's teens and young adults. It develops expert resources and create partnerships. The firm educates and equip students, families and communities. The company was founded in 2000 and is headquartered in New York, NY. | Commercial Services |
Bottom Line
Bottom Line Miscellaneous Commercial ServicesCommercial Services Bottom Line is a non-profit organization. It helps thousands of low-income and first-generation students get to college. The organization was founded in 1997 and is headquartered in Boston, MA. | Commercial Services |
BlackThorn Therapeutics, Inc.
BlackThorn Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blackthorn Therapeutics, Inc. manufactures and markets medicines for neuro developmental disorders. The company is headquartered in San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- John A. MacPhee
